PASITHEA THERAPEUTICS CORP's ticker is and the CUSIP is 70261F111. A total of 8 filers reported holding PASITHEA THERAPEUTICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Warberg Asset Management LLC | 289,868 | $3,799 | 0.00% |
| Kepos Capital LP | 334,600 | $2 | 0.00% |
| Virtu Financial LLC | 85,713 | $1 | 0.00% |
| CLEAR STREET LLC | 100 | $0 | 0.00% |
| ARMISTICE CAPITAL, LLC | 1,000,000 | $6,200 | 0.00% |
| UBS Group AG | 100 | $1 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Citadel Advisors | 12,826 | $190 | 0.00% |
This page lists PASITHEA THERAPEUTICS CORP's shareholders in Q3 2023. To view PASITHEA THERAPEUTICS CORP's shareholder history, click here.